BPC-157 10mg from Adaptog Peptides is a research-grade peptide derived from a protective sequence found in human gastric juice. Investigators value BPC-157 for its well-documented profile across studies on cytoprotection, angiogenesis, and connective-tissue research. The 10mg presentation supports extended protocols and larger working volumes. Adaptog supplies BPC-157 10mg at consistent purity for reliable, reproducible laboratory work.
BPC-157 is one of the most extensively studied peptides in regenerative and cytoprotective research, with a body of literature exploring its activity across gastrointestinal, vascular, and musculoskeletal models. The 10mg vial size from Adaptog Peptides is well suited to laboratories running larger-scale or longer-duration studies that benefit from a single concentrated reagent rather than multiple smaller reconstitutions.
Researchers often buy BPC-157 10mg from Adaptog Peptides for studies such as:
Investigating angiogenesis and vascular endothelial growth factor signalling
Examining cellular migration and fibroblast activity in repair-pathway research
Studying gastrointestinal mucosal protection in controlled models
Mapping interactions between BPC-157 and the nitric oxide system
Because BPC-157 has such a broad and well-characterised research footprint, it remains a foundational reagent across regenerative biology and cytoprotection studies. Adaptog Peptides delivers BPC-157 10mg as a high-purity laboratory compound prepared strictly for qualified research environments. It does not serve any clinical, diagnostic, or therapeutic purpose.
For research use only. Not for human consumption.
BPC-157 is one of the most extensively studied peptides in regenerative and cytoprotective research, with a body of literature exploring its activity across gastrointestinal, vascular, and musculoskeletal models. The 10mg vial size from Adaptog Peptides is well suited to laboratories running larger-scale or longer-duration studies that benefit from a single concentrated reagent rather than multiple smaller reconstitutions.
Researchers often buy BPC-157 10mg from Adaptog Peptides for studies such as:
Investigating angiogenesis and vascular endothelial growth factor signalling
Examining cellular migration and fibroblast activity in repair-pathway research
Studying gastrointestinal mucosal protection in controlled models
Mapping interactions between BPC-157 and the nitric oxide system
Because BPC-157 has such a broad and well-characterised research footprint, it remains a foundational reagent across regenerative biology and cytoprotection studies. Adaptog Peptides delivers BPC-157 10mg as a high-purity laboratory compound prepared strictly for qualified research environments. It does not serve any clinical, diagnostic, or therapeutic purpose.
For research use only. Not for human consumption.
| Type | Synthetic compound |
|---|---|
| Category | Research Compound |
| Purity | ≥99% |
| Form | Lyophilized powder |
-20°C · 24+ months
2–8°C · ~30 days
Third-party tested for purity and quality.
| Variant | GLP3-RT 10mg |
|---|---|
| Lot # | REF0001 |
| Labeled | 20mg |
| Actual | 22.61mg |
| Tested | APR 15, 2026 |
Triple–Hormone-Receptor Agonist GLP-3 (RT) for Obesity — A Phase 2 Trial
2023
DOI: 10.1056/NEJMoa2301972
· Jastreboff AM, et al.
Triple–Hormone-Receptor Agonist GLP-3 (RT) for Obesity — A Phase 2 Trial
2023
DOI: 10.1056/NEJMoa2301972
· Jastreboff AM, et al.
Triple–Hormone-Receptor Agonist GLP-3 (RT) for Obesity — A Phase 2 Trial
2023
DOI: 10.1056/NEJMoa2301972
· Jastreboff AM, et al.
Not a researcher? Exit
